PHI with Eczema flexuarum (undergoing treatment)
How does this condition affect your private health insurance?
Ekzema flexuarum, commonly known as flexural eczema or a manifestation of Atopic Dermatitis, is a chronic inflammatory skin condition characterized by intensely itchy, red, and often scaly patches in the creases of the body, such as the elbows, knees, neck, and ankles. In its ongoing treatment (laufende Behandlung), individuals manage periods of flares and remissions. The skin may become lichenified (thickened) from repeated scratching. It often starts in childhood and can persist into adulthood, significantly impacting quality of life due to discomfort, sleep disturbances, and potential for secondary infections. Management typically involves topical corticosteroids, calcineurin inhibitors, emollients, and lifestyle adjustments.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for an acute flare-up
Duration of Illness (Lifetime)
Chronic, recurring over years to a lifetime
Cost of Treatment (Initial)
Moderate (e.g., doctor visit, topical creams: 50-300 USD)
Cost of Treatment (Lifetime)
High (ongoing prescriptions, specialist visits, emollients, potential biologics: 500-5000+ USD annually, depending on severity)
Mortality Rate
Extremely low (virtually 0%, not directly life-threatening)
Risk of Secondary Damages
High (e.g., bacterial skin infections, sleep disturbances, psychological distress, scarring from chronic scratching)
Probability of Full Recovery
Low (complete cure is rare for chronic Atopic Dermatitis, but long-term remission is possible)
Underlying Disease Risk
Moderate to high (often co-occurs with asthma and allergic rhinitis, known as the atopic triad)